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Enzymatic biomineralization of biocompatible 
CuInS2, (CuInZn)S2 and CuInS2/ZnS core/shell 
nanocrystals for bioimaging† 
 
Leah C. Spangler,   a Roxanne Chu,a Li Lu, b Christopher J. Kiely,a,b 
Bryan W. Berger*a,c and Steven McIntosh *a 
 
 
This work demonstrates a bioenabled fully aqueous phase and room temperature route to the synthesis of 
CuInS2/ZnS core/shell quantum confined nanocrystals conjugated to IgG antibodies and used for fluo-
rescent tagging of THP-1 leukemia cells. This elegant, straightforward and green approach avoids the use 
of solvents, high temperatures and the necessity to phase transfer the nanocrystals prior to appli-cation. 
Non-toxic CuInS2, (CuInZn)S2, and CuInS2/ZnS core/shell quantum confined nanocrystals are syn-
thesized via a biomineralization process based on a single recombinant cystathionine γ-lyase (CSE) 
enzyme. First, soluble In–S complexes are formed from indium acetate and H2S generated by CSE, which 
are then stabilized by L-cysteine in solution. The subsequent addition of copper, or both copper and zinc, 
precursors then results in the immediate formation of CuInS2 or (CuInZn)S2 quantum dots. Shell growth is 
realized through subsequent introduction of Zn acetate to the preformed core nanocrystals. The size and 
optical properties of the nanocrystals are tuned by adjusting the indium precursor concentration and initial 
incubation period. CuInS2/ZnS core/shell particles are conjugated to IgG antibodies using EDC/NHS cross-
linkers and then applied in the bioimaging of THP-1 cells. Cytotoxicity tests confirm that CuInS2/ ZnS 
core/shell quantum dots do not cause cell death during bioimaging. Thus, this biomineralization enabled 
approach provides a facile, low temperature route for the fully aqueous synthesis of non-toxic CuInS2/ZnS 
quantum dots, which are ideal for use in bioimaging applications. 
 
 
 
Introduction 
 
Perhaps the primary biomedical application of quantum con-fined 
semiconductor nanocrystals is as fluorescent markers in cellular 
labeling and bioimaging. Quantum dots are con-sidered superior to 
traditional fluorescent dyes due to their good photo-stability, high 
quantum yields, and long fluo-rescent lifetimes.1,2 Furthermore, a 
wide range of emission wavelengths across the visible and infrared 
regions are accessi-ble by tuning the size or composition of the 
nanocrystal.3 Additionally, quantum dots of the same material, but 
with diﬀ erent sizes, provide a range of diﬀ erent fluorescence wave-
lengths that can be illuminated using the same energy exci- 
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tation source. This is especially desirable for simultaneous tagging 
and identification of diﬀ erent areas or processes within a single 
cell.4,5 
 
To be fully compatible with in vivo biological systems, the 
nanocrystals must be non-toxic, stable in water at physiological pH, 
and readily conjugated to a selective biomarker such as an antibody 
or antigen that binds to a specific receptor on the target cells.2,6 
While cadmium based materials are widely reported for in vitro 
applications, their potential toxicity has prompted research into 
alternative, non-toxic compositions.7,8 CuInS2 is a non-toxic 
semiconductor material that fluoresces in the visible range, in a 
similar manner to CdS.9 While CuInS2 quantum dots typically have 
low fluorescence as syn-thesized, coating or alloying them with ZnS 
has been reported to improve their quantum yield, up to 80% in some 
cases.
10–13 
The requirement for aqueous phase stability at physiologi-cal pH 
is in stark contrast to the typical high temperature organic phase 
quantum dot synthesis procedures. While these routes lead to high 
yields of good quality materials, utilization of an organic based 
synthesis route requires additional proces-sing to transfer the 
nanocrystals into the aqueous phase using either ligand exchange or 
encapsulation in a polymer shell or 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
micelle.2,3,6 Furthermore, these organic syntheses procedures often 
utilize toxic precursors which could cause contamination in the final 
product.14 All of these factors have motivated our research towards 
developing an aqueous based synthesis route for biocompatible 
quantum confined CuInS2 nanocrystals. 
 
Several groups have been investigating the aqueous chemi-cal 
synthesis of quantum dots to avoid an additional phase transfer 
step.15 While there has been some success, many of these techniques 
still require high temperatures and/or press-ures to generate 
crystalline particles. This requirement increases cost and limits 
potential scale-up for use in indus-trial biomedical applications. 
 
There are many proposed aqueous synthesis routes for CuInS2 
based quantum dots. The most common procedure described is the 
hydrothermal method, performed in an auto-clave at 100–150 °C 
and at pH 11 or higher.16–18 Typically, chloride salts of copper and 
indium are used in addition to a reactive sulfur precursor such as 
thiourea or Na2S. In a few cases, (CuInZn)S2 quaternary alloys have 
been formed by also adding zinc acetate or zinc chloride.19,20 
Commonly used capping agents include MPA, glutathione, and L-
cysteine. Many groups have successfully applied the resulting 
materials for bioimaging of cancer cells. Xiong et al. have utilized 
similar precursors and reaction conditions, but eliminated the need 
for high pressure conditions by heating to 100 °C using microwave 
irradiation.21 Additionally, a ZnS shell is frequently grown on these 
materials to improve the fluorescence pro-perties of the 
nanocrystals. The resulting glutathione capped CuInS2/ZnS 
core/shell quantum dots are used without conju-gation for cell 
labeling, or conjugated to an antibody for a fluoroimmunoassay that 
can be used for early detection of cancer. Chen et al. demonstrated 
another open-air procedure to synthesize glutathione capped 
CuInS2/ZnS core/shell nano-crystals.22 Copper and indium salts 
were heated at 95 °C with Na2S as a reactive sulfur precursor to 
form CuInS2 nanocrys-tals, and subsequent growth of a ZnS shell 
was achieved by further heating the solution in the presence of zinc 
acetate and thiourea. 
 
 
Wang et al. have proposed that significant energy and 
environmental cost savings can be achieved by greener nano-crystal 
synthesis that can occur at ambient temperature without a harsh 
chemical environment.23 The aqueous syn-thesis approach they 
describe occurs at, or below, room temp-erature at a pH of 7.4 
utilizing copper sulfate, indium chloride, thioacetamide as sulfur 
source, and the protein bovine serum albumin (BSA) as a capping 
agent. While this approach formed nanocrystals, no 
photoluminescence was reported and the synthesis procedure 
required about 100 h to complete, most likely due to the slow 
decomposition rate of the thio-acetamide. This long synthesis time 
negatively impacts the potential economics of the production route 
and is a common criticism of green approaches to nanoparticle 
synthesis. In the absence of elevated temperature, pH or direct 
addition of a reactive chemical precursor, an additional driving force 
is required to achieve aqueous phase nanocrystal formation under 
ambient conditions at shorter timescales. 
 
Herein we have drawn inspiration from biological systems, and 
demonstrate the single enzyme catalyzed biomineral-ization of 
quantum confined CuInS2, (CuInZn)S2 and CuInS2/ ZnS core/shell 
nanocrystals and demonstrate their eﬃcacy in the bioimaging of 
THP-1 leukemia cells. Biomineralization is the process whereby 
biological systems mineralize inorganic materials.24 In contrast to 
bio-inspired approaches that typi-cally utilize a biomolecule to 
template chemically induced mineralization,25–27 we have recently 
developed a single-enzyme based approach that enables direct 
biomineralization of aqueous stable quantum confined nanocrystals 
from the fewest possible components at ambient temperature.28 
Mineralization is catalyzed in otherwise inert solutions by the 
enzymatic turnover of the amino acid L-cysteine to form reactive 
H2S as a sulfur source which then reacts with metal salts in solution. 
The L-cysteine serves a dual role as sulfur source and capping agent. 
We have previously demonstrated 
 
this approach for non-biocompatible materials such as CdS and 
CdSe.28,29 In this current work, we demonstrate the 
biomineralization of non-toxic, biocompatible CuInS2, (CuInZn)S2 
and CuInS2/ZnS quantum dots for bioimaging applications. 
 
 
 
Experimental 
 
CSE was overexpressed and purified from recombinant E. coli cells, 
as reported previously.28 Briefly, E. coli was grown to sat-uration at 
37 °C and then diluted to an initial OD600 of 0.8. Expression was 
induced using 1 mM IPTG and performed for 16 h at 20 °C. After 
expression, the cells were harvested using centrifugation at 3000g, 
re-suspended in lysis buﬀ er (10 mM imidazole, 100 mM HEPES, 
500 mM NaCl, 10% glycerol), and sonicated at 12 W for 10 seconds 
on/10 seconds oﬀ  at 4 °C. This cell lysate was centrifuged at 8500 
rpm to purify the supernatant containing the recombinant CSE. The 
supernatant was then further purified using immobilized metal 
aﬃnity chromatography (IMAC). The IMAC column contained Ni-
NTA chelating sepharose (GE Healthcare) and the cell lysate was 
eluted using increasing concentrations of imidazole buﬀ er (20 mM 
HEPES, 500 mM NaCl, 10% glycerol, and 10–500 mM imidazole). 
The CSE was stored in imidazole buﬀ er until use. 
 
CuInS2 nanocrystal growth was performed by incubating indium 
nitrate (4 mM, Alfa Aesar Puratronic), L-cysteine (16 or 32 mM, 
Spectrum Chemicals, 99.55%), and CSE (0.1 mg mL−1 or 0.2 mg 
mL−1) in Tris-HCl buﬀ er (0.1 M, pH 7.5) for 2–6 h at 37 °C. After 
verifying the presence of a 290 nm peak in the absorbance spectrum, 
which indicates the formation of <1 nm indium sulfide complexes, 
copper acetate (2 mM, Alfa Aesar Puratronic, 99.99%) was added to 
the solution. The solution immediately turned yellow, orange, or red, 
depending on the size of the nanocrystals formed. Subsequent shell 
growth was performed by adding zinc acetate (2 or 4 mM, Alfa 
Aesar Puratronic) to the CuInS2 sol after 1 h of incubation at room 
temperature. The sols were then left to incubate at room temp-erature 
for 1–16 h. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(CuInZn)S2 quaternary alloy quantum dots were synthesized in a 
similar manner to the CuInS2 nanocrystals. Indium nitrate (4 mM) 
was incubated with L-cysteine (32 mM) and CSE (0.2 mg mL−1) for 
4 or 6 h. Then, copper acetate (2 mM) and zinc acetate (4 mM) were 
added simultaneously to the solu-tion, resulting in an instantaneous 
color change from clear to yellow. 
 
The biosynthesized nanocrystals were analyzed without any 
further purification steps. Optical absorbance measurements were 
performed using a UV-Vis 2600 spectrophotometer equipped with 
an ISR-2600-Plus integrating sphere attachment (Shimadzu). 
Photoluminescence spectra were obtained using a QuantaMaster™ 
400 (Photon Technology International) or a Fluorolog-3 
spectrofluorometer (Horiba). Photoluminescence lifetime 
measurements were obtained using the Fluorolog-3 
spectrofluorometer with attached Time-Correlated Single Photon 
Counting (TCSPC) controller. The excitation source was a 478 nm 
laser (Delta Diode). The photoluminescence life-times were 
calculated from the decay curves using a bi-expo-nential fit. 
Quantum yield (QY) values were determined using the reference dye 
Coumarin 153 in ethanol.30 
 
Samples used for transmission electron microscopy analysis were 
first diluted 100× in DI water. Next, a single drop was dis-persed 
onto a holey carbon coated Ni or Au-mesh grid and the liquid 
allowed to evaporate at room temperature in a vacuum overnight. 
The samples were then analyzed using an aberra-tion corrected 
JEOL ARM 200CF analytical electron microscope operating at 200 
kV equipped with a JEOL Centurio X-ray energy dispersive 
spectroscopy (XEDS) system. Samples used for XEDS analysis in 
the scanning electron microscope were precipitated from aqueous 
solutions using ethanol three times and then dispersed on a glass 
microscope slide to dry. The dried powder was then mounted onto 
conductive carbon tape and imaged using a Zeiss 1550 FEG-SEM 
equipped with an Oxford Instruments XEDS detector. 
 
Quantum dot–antibody conjugates were formed using 1-ethyl-3-
(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) and N-
hydroxysulfosuccinimide (NHS) cross-linkers,31 obtained from 
Thermo Fisher Scientific. Prior to conjugation, the quantum dots 
were buﬀ er exchanged from Tris-HCl to phosphate buﬀ ered saline 
(PBS, 10 mM) using successive concentration and re-suspension via 
centrifugation filters (9 K, Thermo Fisher Scientific). 10 μL of an 
EDC solution (20 mg mL−1, Thermo Fisher Scientific) and 1 μL of 
NHS (20 mg mL−1, Thermo Fisher Scientific) were added to 100 μL 
of a con-centrated CuInS2/ZnS quantum dot solution. The EDC 
solution was prepared immediately prior to use to prevent 
hydrolysis. The solutions were briefly centrifuged to remove any 
precipi-tated nanocrystals and then 100 μL of 151-IgG (specific for 
epi-dermal growth factor receptor; EGF receptor) was added to the 
solution (DSHB Hybridoma Product 151-IgG or 151-8 AE4).32 The 
quantum dot bioconjugate solutions were then incubated for 1 h at 
37 °C. 
 
THP-1 cells were maintained at 37 °C under 5% CO2 in RPMI 
1640 medium containing 10% FBS. The cells were grown to 
confluence and then 50 µL of either the buﬀ er exchanged 
 
quantum dots or the quantum dot–antibody mixture were added to 
300 µL of the cell solution. THP-1 cells were de-posited onto 
ibiTreat μ-Dishes (Ibidi, Martinsried, Germany), treated with poly-L-
lysine. These cells were then incubated at 37 °C for 3 h. The cells 
were washed twice with PBS buﬀ er prior to optical microscopy 
analysis.31 The μ-Dish, containing the THP-1 cells and quantum dot 
antibody mixture, was imaged using a Nikon C2si+ confocal 
microscope equipped with a LU-N4S laser unit and a 40× air 
objective (NA = 0.95). The images were processed using Elements 
version 4.3 (Nikon) and Fiji. To check for cell viability in the 
presence of quantum dots, a Trypan blue assay was used to 
determine the quantity of living cells every 20 minutes over a period 
of 6 h.33 The approximate cell seeding density employed was 4.5 × 
105 cells per mL. Cell viability remained at or above 95% over the 
entire time-period. 
 
 
 
Results 
 
Incubation of CSE with a buﬀ ered solution of copper acetate leads to 
the appearance of an optical absorption onset at ∼700 nm, which is in 
agreement with that expected for the for-mation of Cu2−xS 
nanocrystals, Fig. 1(a). This process is similar to the 
biomineralization of CdS and PbS as previously reported by our 
group.28,34–36 Mineralization occurs as H2S is generated by the 
enzymatic turnover of L-cysteine by CSE. This H2S then reacts with 
the metal salt in solution to form the metal sulfide. This process is 
analogous to the chemical route to aqueous phase sulfide 
mineralization whereby reactive Na2S is added to induce 
mineralization of, for example, Cu2−xS.37 The formation of 
nanoparticles, as opposed to bulk materials, 
 
is due to (i) the presence of the L-cysteine which can act as a capping 
agent,38,39 and (ii) the templating ability of the CSE enzyme itself.28 
Unfortunately, no corresponding fluorescence peak could be 
observed due to a very low fluorescence inten-sity. This is a common 
issue with Cu2−xS nanocrystals, and is typically attributed to 
oxidation of as-synthesized stoichio-metric Cu2S nanocrystals to 
form non-fluorescing non-stoi-chiometric Cu2−xS. Hence, 
fluorescence data for these Cu2−xS materials is rarely reported. To 
our knowledge, only two groups have reported such data for Cu2−xS 
materials which were synthesized under strictly oxygen free 
conditions.40,41 
 
Similar incubation of CSE in a buﬀ ered solution of indium 
nitrate leads to the appearance of an absorbance peak centered at 290 
nm that grows in intensity with increasing incubation time, Fig. 1(b). 
A peak at the same position is observed when indium and Na2S are 
combined in the presence of L-cysteine, Fig. S1.† When L-cysteine is 
not present in solution, a cloudy solution forms with no strong peak 
at 290 nm. This suggests the formation of bulk indium sulfide and 
indium hydroxide precipitates, which occur at neutral and basic 
pH.42 The peak position at 290 nm is in agreement with prior reports 
and is due to the formation of small (<1 nm) molecular indium 
sulfide clusters.43–46 No shift in the absorbance spectra was 
observed, indicating that the clusters remain the same size 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1 Absorbance spectra of (a) Cu2−xS nanocrystals and (b) In–S 
complex solutions as a function of time when synthesized by incubation of 
CSE, L-cysteine and copper acetate or indium nitrate, respectively. 
 
 
 
over the incubation period. The growth in intensity of this peak with 
synthesis time is indicative of an increasing concen-tration of these 
clusters, formed as the enzyme turns over more of the L-cysteine to 
form H2S. In support of this concept, doubling the concentration of 
L-cysteine and CSE was found to increase the rate of growth in peak 
intensity, see Fig. S2,† demonstrating an increased synthesis rate of 
the molecular clusters. Therefore, while reaction with transition 
metals leads to the formation of solid precipitates,47 reaction with 
indium leads to the formation of ultra-small soluble clusters. 
 
The addition of 2 mM copper acetate to solutions contain-ing 
these biomineralized In–S clusters leads to an immediate change in 
solution color to yellow, orange or red, Fig. 2(a). Both the solution 
color and absorbance spectra, Fig. 2(b), are consistent with the 
formation of CuInS2 nanocrystals, agreeing with previously reported 
data for CuInS2 formed by chemical synthesis routes.9,48–51 The 
sequential method of synthesis is 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 (a) Photographs of solutions upon addition of 2 mM Cu acetate to 
solutions of CSE, L-cysteine and indium nitrate previously incubated for the 
time-period indicated and with the specified cysteine precursor 
concentrations. The corresponding absorbance and photoluminescence 
spectra of this set of materials are shown in (b) and (c) respectively. The 
 
* in (c) denotes the Raman peak of water which is not part of the quantum 
dot fluorescence. 
 
 
 
required in order to prevent the nucleation of a secondary population 
of Cu2−xS nanoparticles, shown by the altered absorbance peak 
shape and formation of a brown solution 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
(Fig. S3†). The absorbance peak of the CuInS2 quantum dot 
solutions was found to shift to longer wavelength positions with 
increasing incubation time and increasing L-cysteine con-centration 
in the original indium containing solution. The shift in absorption 
peak wavelength is indicative of larger par-ticles forming with 
increasing In–S precursor concentration. The band gap values for 
each solution shown in Fig. 2 were cal-culated using a Tauc plot and 
range from 2.35 to 1.93 eV, Table S1.† These band gap values 
indicate the formation of quantum confined nanocrystals with band 
gap values above 1.53 eV, which is the reported bulk band gap of 
CuInS2. 
The fluorescence from these samples is low (Fig. 2c), most likely 
suppressed due to the presence of surface defects result-ing from the 
low temperature, aqueous synthesis.22 For crystal-line nanoparticles 
synthesized with 16 mM cysteine, photo-luminescence peaks were 
obscured by fluorescence from the enzyme. However, a small 
shoulder could be identified at around ∼600 nm in Fig. 2(c) for the 
case of a 4 h indium incu-bation. Solutions synthesized with 32 mM 
cysteine exhibit photoluminescence peaks shifting from 615 nm to 
650 nm after 2 or 4 h indium incubation, respectively. After 6 h 
indium incubation, the photoluminescence peak no longer shifts but 
appears to decrease in intensity. This suggests the maximum number 
of In–S complexes has been generated in solution after 4 h In 
incubation, so larger crystals are no longer able to form. 
 
 
Some groups have also reported that changes in the rela-tive Cu 
and In compositions (as well as size) can cause shifts in the optical 
spectra of CuInS2 quantum dots.52–54 Quantitative SEM-XEDS 
analysis was utilized to determine the compositions of quantum dots 
for three diﬀ erent indium incubation times. For CuInS2 solutions 
made with 16 mM cysteine and 4 h In incubation time, the Cu/In 
ratio was 1.6 ± 0.09. When 32 mM cysteine was used with In 
incubation times of 4 or 6 h, the Cu/In ratios were found to be 0.7 ± 
0.04 and 0.6 ± 0.04, respectively. As previously shown in Fig. 1(b) 
and S2,† a lower concentration of cysteine decreases the number of 
In–S complexes; therefore, a higher Cu/In ratio is expected for the 
16 mM cysteine sample. When more In–S complexes are present, 
(as in the latter two samples) the CuInS2 nanocrystals appear to be 
Cu deficient. Typically, such Cu deficient CuInS2 nanocrystals have 
blue-shifted optical properties. As our nanocrystal solutions prepared 
with 
 
32 mM cysteine continue to show a red-shift in absorbance 
properties relative to the 16 mM sample, we believe the change in 
optical properties noted is being dominated by 
 
competing quantum confinement eﬀ ects arising from par-ticle size 
variations.50,55 
 
Fig. 3(a) shows an HRTEM phase contrast image of a repre-
sentative CuInS2 nanocrystal from the 32 mM cysteine, 4 h In 
incubation specimen shown in Fig. 2(b). A corresponding lower 
magnification HRTEM image showing a larger sampling of these 
nanocrystals is presented in Fig. S4.† The nanocrystal diameter is 
approximately 2.5 nm, which suggests that the quantum dot 
solutions should have a photoluminescence peak at ∼650 nm when 
compared to literature reports for 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 (a) HRTEM phase contrast image and (b) the corresponding FFT of 
a single 2.5 nm CuInS2 nanocrystal. Fitting of the interplanar spacings and 
angles of the planes in the FFT are reported in Table S2† and are 
consistent with the chalcopyrite crystal structure viewed along [103¯ ]. 
 
(c) Single particle STEM-XEDS analysis confirms the co-existence of Cu, 
In, and S within the particle. 
 
 
 
chemically synthesized quantum confined CuInS2 nanocrystals with 
a Cu/In ratio of 0.7.49 As expected, the optical properties of our 
material are blue-shifted from chemically synthesized nanocrystals 
of 2.7 nm mean diameter and 1 : 1 Cu : In stoi-chiometry, which are 
reported to have a photoluminescence peak at around 700 nm.55 The 
corresponding fast Fourier transform (FFT) derived from Fig. 3(a) 
and shown in Fig. 3(b) can be indexed to the [103ˉ] projection of the 
chalcopyrite struc-ture of CuInS2, Table S2.† A representative X-ray 
energy disper-sive spectrum (STEM-XEDS) from an isolated 
particle, Fig. 3(c), confirms the co-existence of indium, copper, and 
sulfur within a single particle. The copper peaks have a slight 
overlap with Ni, which is present from the TEM support grid. 
HRTEM phase contrast images of nanocrystals formed from a 
solution of 4 mM indium, 16 mM L-cysteine, 0.1 mg mL−1 CSE for 
4 h initial indium show even smaller, ∼2 nm particles (Fig. S5†). 
Again, the corresponding photoluminescence peak at ∼600 nm is 
consistent with those reported for 2 nm chemically synthesized 
particles of similar composition.22 
 
Many groups have shown that the growth of a ZnS shell on 
CuInS2 quantum dots significantly increases the quantum yield. We 
have previously reported biomineralization of PbS/ CdS core/shell 
particles through the sequential addition of pre- 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4 Absorbance and photoluminescence spectra of CuInS2/ZnS core/shell nanocrystals grown with increasing incubation time at room temperature. 
 
 
 
 
cursors.
34
 Incubation of CSE in a buﬀ ered solution of zinc acetate 
and L-cysteine leads to the formation of an absorption peak at 280 
nm, Fig. S6,† in agreement with reports of ZnS nanoparticle 
formation.56–58 As such, we adapted our pre-viously demonstrated 
procedure to incubate CuInS2 core nano-particles in a buﬀ ered zinc 
acetate solution with L-cysteine and CSE. Fig. 4 shows the 
absorbance and photoluminescence spectra of the resulting material 
as a function of increasing incubation time with zinc acetate. 
Although the absorbance spectrum remains essentially unchanged 
except at the longest growth time, the photoluminescence properties 
improve dra-matically over time. The photoluminescence peak 
slightly blue shifts relative to that of the core CuInS2 nanocrystals, 
indicat-ing the growth of a ZnS shell. Although core/shell quantum 
dots typically have photoluminescence spectra which are red-shifted 
from the core nanocrystals, many groups report a blue shift with 
CuInS2/ZnS core/shell quantum dots and attribute 
 
this to a slight etching of the CuInS2 core size during shell 
growth.13,55 The quantum yield of the as synthesized CuInS2/ 
 
ZnS quantum dots was determined to be approximately 0.1% 
relative to the standard dye Coumarin 153 in ethanol. While this 
quantum yield is low compared to previous reports of CuInS2/ZnS 
prepared in the aqueous phase,22 these latter methods required high 
temperature and/or pressure to form the nanocrystals. Poor 
photoluminescence quantum yields are commonly found for 
biomineralized quantum dots made at low temperatures, and 
ongoing work is focused on further improving the overall quantum 
yield while retaining the appli-cation advantages of an aqueous 
synthesis procedure that operates under ambient conditions. 
 
Fig. 5(a and b) shows some representative HRTEM phase 
contrast images of the biomineralized CuInS2/ZnS core/shell 
nanocrystals. A lower magnification image is shown in Fig. S7.† 
The crystals are approximately 4 nm in diameter, which is larger 
than the typical corresponding core nanocrystal shown in Fig. 2(a). 
The lattice spacings and interplanar angles derived from the 
corresponding FFT’s for both particles, Fig. 5 (c and d), can be 
assigned to the [010] projection of chalco-pyrite structure of CuInS2, 
Table S3.† Based on the measured photoluminescence maxima of 
630 nm for this material, we 
 
would expect the CuInS2 core of these nanocrystals to be 
approximately 2–2.5 nm.55,59 Assuming no intermixing of the core 
and shell materials, the increased overall size of the observed 
quantum dots suggests the growth of a ∼0.75 nm thick ZnS shell on a 
∼2.5 nm diameter core. The lattice para-meter for sphalerite ZnS is 
0.58 nm, suggesting the growth of ∼1.5 monolayers. The growth of 
an epitaxial shell is consistent with previous reports of chemically 
synthesized CuInS2/ZnS core/shell particles12,13 and is expected for 
this system because CuInS2 and ZnS (the sphalerite form) have a 
lattice mismatch which is less than 2%.11 Single particle STEM-
XEDS analysis, Fig. 5(e), confirms the co-existence of copper, 
indium, sulfur and zinc within individual particles. It was not 
possible using either HRTEM phase contrast or HAADF-STEM 
imaging modes to see a direct contrast diﬀ erence between the core 
and shell material in this materials system. 
 
The average composition of the same CuInS2/ZnS core/shell 
particle preparation shown in Fig. 5 was analyzed using SEM-EDS. 
The Cu/In ratio was found to be 1.46 ± 0.18 (as com-pared the core 
material which had a Cu/In ratio of 0.7 ± 0.04) and the Zn/In ratio 
was 2.3 ± 0.29. The increase in Cu/In ratio relative to the starting 
core material suggests that the zinc is preferentially substituting for 
indium cations in the crystal lattice, as no additional copper was 
added to the solution during ZnS shell growth. This decrease of 
indium has also been reported by Chen et al., who also utilized an 
aqueous syn-thesis method in open air. In a similar manner to our 
system, they observed a reduction of indium content for CuInS2/ZnS 
core/shell nanocrystals that have Cu/In ratios of less than 1 in the 
starting CuInS2 core quantum dots.22 
 
Several groups have also reported that the mixed quaternary 
(CuInZn)S2 alloy shows improved photoluminescence pro-perties 
over CuInS2 nanocrystals.19,60,61 To determine whether 
biomineralization with CSE was capable of producing a qua-ternary 
alloy, we simultaneously added zinc acetate and copper acetate to a 
solution of 4 mM indium acetate, 32 mM L-cysteine, and 0.2 mg 
mL−1 CSE which had been incubated for 4 hours. Fig. 6 shows 
images, absorbance spectra, and photoluminescence spectra of the 
resulting ‘quaternary’ sols compared to that for sols of CuInS2 and 
sequentially prepared 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5 (a, b) HRTEM phase contrast images and (c, d) the corresponding 
FFT’s of 4 nm CuInS2/ZnS nanocrystals with cores grown with 32 mM cys, 
4 h In incubation time and Zn acetate in solution for 12 h viewed along the 
[010] projection. Lattice fitting of the planes in the FFT are presented in 
Table S3.† (e) Representative STEM-XEDS spectrum showing the co-
existence of Cu, In, S, and Zn within a single particle. 
 
 
 
CuInS2/ZnS core/shell nanoparticles. The absorbance and fluo-
rescence peaks of the (CuInZn)S2 material are both signifi-cantly 
blue shifted from those of the CuInS2 quantum dots formed from the 
same In–S complex solution, consistent with 
 
the expected optical properties for quaternary alloy quantum 
dots.61,62 Additionally, the level of fluorescence is significantly 
 
improved compared relative to the CuInS2 quantum dots, but was 
still not able to match the improved peak intensity shown by the 
‘core/shell’ type particles which had zinc acetate added after the 
formation of the CuInS2 core. This indicates that adding zinc with 
copper does in fact produce an intimately mixed quaternary alloy, 
whereas adding zinc after the initial 
 
 
 
 
 
 
 
 
 
 
Fig. 6 (a) Images, (b) absorbance spectra, and (c) photoluminescence 
spectra showing the diﬀerence between the original CuInS2 quantum dot 
sol and those materials synthesized with sequential addition versus 
simultaneous addition of Cu and Zn precursors leading to the formation of 
a CuInS2/ZnS core/shell morphology or a (CuInZn)S2 random alloy, 
respectively. 
 
 
 
CuInS2 quantum dots are formed produces a more core/shell type 
morphology. 
 
Fig. 7(a) shows an HRTEM phase contrast image of a 
representative (CuInZn)S2 nanocrystal from the sol whose optical 
properties are shown in Fig. 6. The particles appear to 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7 (a) HRTEM phase contrast image and (b) corresponding FFT of a 
representative 5 nm (CuInZn)S2 nanocrystal viewed along the [021¯ ] pro-
jection. Lattice fitting of planes indicated in the FFT are reported in Table 
S4.† (c) Representative STEM-XEDS spectrum showing the co-existence 
of Cu, In, S, and Zn within the single nanoparticle. 
 
 
 
 
be ∼5 nm in diameter and have a more irregular shape as compared 
to the corresponding CuInS2 and CuInS2/ZnS core/ shell particles. 
The photoluminescence peak at 575 nm is blue-shifted in 
comparison to other reports for 4–5 nm (CuInZn)S2 nanocrystals 
with a nominal 1 : 1 : 1 stoichiometry of Cu : In : Zn cations. 
However, the cationic ratios measured using SEM-EDS was 1.84 ± 
0.13 for Cu/In and 2.07 ± 0.14 for Cu/Zn. Similar to the core/shell 
nanocrystals, the Cu/In ratio is significantly increased with the 
incorporation of Zn as compared to the CuInS2 core-only material. 
Jiang et al. have reported a significant blue-shift in the optical 
properties for (CuInZn)S2 nanocrystals having a small indium 
content rela-tive to zinc.19 The low indium content in addition to 
high zinc content in the alloy sample may play a dominant role in 
determining the optical properties as opposed to size quanti-zation in 
this case. Fig. 7(b) shows the corresponding FFT for the particle 
imaged on Fig. 7(a) which matches well to the [021ˉ] projection of 
the chalcopyrite phase (see lattice fringe fitting in Table S4†). A 
STEM-XEDS spectrum acquired from a single nanoparticle is 
shown in Fig. 7(c) and confirms that copper, indium, zinc, and sulfur 
all co-exist in a single particle. No separate nucleation of Cu2−xS, 
In2S3, or ZnS nanocrystals was detected in our electron microscopy 
analyses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8 Time resolved photoluminescence decay curves for the CuInS2 core 
nanocrystals only, the (CuInZn)S2 quaternary alloy and the CuInS2/ ZnS 
core/shell nanocrystals. 
 
 
 
This proposition of core/shell formation versus quaternary alloy 
formation is further verified through photoluminescence lifetime 
measurements of core CuInS2, alloy (CuInZn)S2, and core/shell 
CuInS2/ZnS nanocrystals, as shown in Fig. 8. CuInS2 particles 
typically have two decay lifetimes; the first, a short lifetime (∼10–50 
ns) and second longer lifetime (∼100–500 ns), have been assigned to 
non-radiative and radiative decay processes, respectively.9,10 
Because our CuInS2 core-only nano-crystals have poor 
photoluminescence characteristics, overall shorter lifetimes of 2.4 ns 
and 13.9 ns for these two processes were observed. The time 
constants increase slightly to 2.8 ns and 31 ns, respectively, for the 
(CuInZn)S2 quaternary alloy nanocrystals. Both time constants 
increase markedly to 9.4 ns and 74.5 ns respectively, upon 
incubation of CuInS2 in the zinc acetate containing solution to form 
CuInS2/ZnS core/shell nanocrystals. In the case of the (CuInZn)S2 
alloyed nanocrys-tals, the increase in the decay emission is attributed 
to a slight passivation of donor defects within the crystal lattice.61 
The substantial increase in the radiative decay lifetime for the 
CuInS2/ZnS core/shell type quantum dots is a typical result of 
increased surface passivation upon growth of a shell onto core 
nanocrystals.10 
 
To demonstrate that our biomineralized CuInS2/ZnS core/ shell 
nanocrystals could be eﬀ ective for bio-labeling, the as-synthesized 
quantum dots were conjugated to IgG antibodies using EDC/NHS 
cross-linkers, which then bind to the epidermal growth factor 
receptor (EGFR) of the THP-1 leukemia cells. THP-1 is an 
established cell line used for biomarker detection 
 
in cancer and contains the target receptor of interest, namely 
EGFR.63,64 Fig. 9(a) shows a confocal image of THP-1 cells incu- 
 
bated with CuInS2/ZnS nanocrystals that had not yet been con-
jugated to anti-EGFR antibody. The red signal indicates fluo-
rescence from the CuInS2/ZnS quantum dots, which is even across 
the sample, confirming no site-specific fluorescence inside the cells. 
In contrast, Fig. 9(b) shows a confocal image of THP-1 cells after 1 
h of incubation with CuInS2/ZnS quantum 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9 Light optical confocal microscope images of THP-1 cells 
 
(a) incubated in solution with CuInS2/ZnS quantum dots with no IgG 
antibody tagging, and (b) tagged with CuInS2/ZnS quantum dots, bio-
conjugated to an IgG antibody. The red coloration corresponds to quantum 
 
dot fluorescence, and is only site specific when the IgG antibody on the 
THP-1 leukemia cells are conjugated to the CuInS2/ZnS nanocrystals. 
 
 
 
 
dots tagged with IgG. The cells were washed twice prior to imaging 
in the confocal light-optical microscope to remove any unbound 
quantum dots. The fluorescence from the CuInS2/ZnS quantum dot-
IgG conjugates is localized to patches on the cell surface; a similar 
pattern of EGFR clustering at the cell surface has been described 
before due to the dimer-dependent acti-vation of EGFR.65,66 The 
absence of site specific fluorescence in Fig. 9(a) confirms that the 
CuInS2/ZnS quantum dots were not taken into to cells using already 
present endocytosis or phago-cytosis pathways, which has been 
previously reported for small nanocrystals.67,68 In order to monitor 
the toxicity of quantum dots, a Trypan blue assay was utilized to 
determine the percent-age of dead THP-1 cells after incubation with 
the CuInS2/ZnS quantum dot solution. Over a period of 6 h, the 
percentage of living cells remained at an average of 95.5% ± 2.6%, 
demon-strating that the quantum dots have little or no adverse toxic 
eﬀ ect on the target THP-1 cells. 
 
Discussion 
 
The biomineralization of CuInS2 or (CuInZn)S2 nanocrystals 
requires a slightly more complex approach than the straight-forward 
direct biomineralization from buﬀ ered solutions of 
metal salt, L-cysteine and CSE demonstrated for Cu2−xS and ZnS 
herein, and for PbS and CdS in our previous work.34,35 These latter 
materials will directly form a metal sulfide solid upon reaction with 
the reactive sulfur, likely H2S, formed by the enzymatic turnover of 
L-cysteine by the putative cystathio-nine γ-lyase class CSE 
enzyme.28 In contrast, reaction with indium nitrate forms a relatively 
stable species with a charac-teristic absorption peak at 290 nm, 
which has previously been identified as a molecular cluster of 
indium and sulfur,46 rather than bulk or nanocrystalline In2S3. A 
similar result is obtained upon addition of Na2S to a mixture of 
indium nitrate with L-cysteine, whereas a bulk precipitate of In2S3 
likely combined with indium hydroxide is formed in the absence of 
L-cysteine. Thus, it appears that L-cysteine acts to stabilize these 
clusters. Formation of CuInS2 or (CuInZn)S2 nanocrystals can be 
initiated by reaction of copper acetate, or copper acetate and zinc 
acetate, in solutions containing these biologically gener-ated clusters 
containing indium and sulfur. 
 
The biomineralized CuInS2 and (CuInZn)S2 nanocrystals 
produced are within the quantum confined size range and exhibit 
crystal structures, lattice parameters and optical absor-bance maxima 
positions that are equivalent to their chemically synthesized 
counterpart materials. Single particle XEDS ana-lysis confirms the 
co-existence of the constituent elements within individual particles. 
As further verification, a chemical aqueous synthesis of CuInS2 
prepared via the addition of reac-tive Na2S to a solution of copper 
acetate, indium chloride and L-cysteine templating agent,22 forms 
nanocrystals with optical properties analogous to our purely 
biomineralized materials. In the chemical synthesis case, Na2S acts 
as the reactive sulfur source in place of the enzymatic generation of 
H2S by CSE. Thus, our biomineralization approach is capable of 
producing biocompatible quantum dots in the aqueous phase under 
ambient conditions. Unfortunately, the photoluminescence 
characteristics of these ‘as-generated’ nanoparticles are quite low, 
indicative of poor surface passivation in the aqueous phase due to the 
low synthesis temperature employed. 
 
Photoluminescence from CuInS2 and (CuInZn)S2 nanocrys-tals is 
thought to occur from intrinsic defects in the crystal structure, 
although the exact decay pathway is still a matter of debate.9 This 
leads to relatively wide peak widths, as indicated by large full-width-
half-maxima (FWHM) of ∼300 meV, even 
 
with size selective precipitation, and a large Stokes’ shift of ∼450 
meV.10,50,69 Our aqueous phase, room temperature bio-synthesized 
nanocrystals display similar FWHM values of 300, 590 and 430 
meV, and a Stokes shift of 400, 300 and 650 meV, for the CuInS2, 
(CuInZn)S and CuInS2/ZnS, particle variants respectively. Our 
Stokes shift values are slightly larger than those reported for 
analogous chemically prepared materials (cf. ∼400 meV for 
CuInS2/ZnS quantum dots chemically syn-thesized in the aqueous 
phase at 95 °C).22 The (CuInZn)S2 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
quaternary alloy nanocrystals have a significantly higher FWHM, 
which is to be expected based on their highly irregular shapes.19 
 
The low photoluminescence intensity of the as-synthesized 
CuInS2 nanocrystals is most likely due to the presence of surface 
trap states that lead to non-radiative recombination pathways,11 and 
cause the short lifetimes reported in Fig. 6. The improvement in both 
photoluminescence intensity and lifetimes for the (CuInZn)S2 alloy 
nanocrystals relative to CuInS2 is most likely due to passivation of 
defects within the crystal lattice. Further improvement in 
photoluminescence and lifetimes is achieved through passivation of 
surface defects through the growth of a ZnS shell on the CuInS2 
nano-crystals. While from electron microscopy studies we cannot 
completely exclude the possibility of some limited zinc diﬀusion 
into the CuInS2 particles rather than solely forming a ZnS overlayer, 
shell growth is indicated by the substantial improvement in 
photoluminescence intensity and lifetime when compared to the 
corresponding fully alloyed (CuInZn)S2 particles. 
 
 
CuInS2 and (CuInZn)S2 nanocrystals are typically formed at high 
temperature in an organic phase and must be phase transferred and 
stabilized in the aqueous phase prior to appli-cation as a fluorescent 
marker in biological systems.11,12 While this chemical approach 
leads to high quality materials in terms of quantum yield, it is an 
energy intensive and more complex synthesis route which is 
intrinsically far away from the generally desirable ethos of green 
production of materials. In contrast, the direct biomineralization 
approach demon-strated in this paper results in the fabrication of 
stable quantum confined nanocrystals directly in the aqueous phase 
at room temperature. 
 
Bioimaging applications generally require stable, aqueous phase 
nanocrystals that can be functionalized with a biological marker, 
such as an antibody. While CuInS2 and (CuInZn)S2 nanocrystals are 
typically chemically synthesized in the organic phase, they then need 
to be transferred into water using ligand exchange, or more 
commonly, encapsulation in a polymer shell, such as PEG.13 
Notably, any phase transfer procedure typically reduces the quantum 
yield,12,13 while ligand exchange also reduces the stability of the 
quantum dots.6 Polymer encapsula-tion also inevitably results in 
nanocrystals which are much larger than their initial nominal size.2 
Our biomineralized quantum dots have the advantage of being 
synthesized in bio-logically relevant aqueous buﬀ ers, and have high 
stability while still retaining an ultra-small size. They do not require 
any additional processing steps after synthesis and can be conju-
gated to antibodies directly from the synthesis solution without 
adversely aﬀ ecting cell-surface binding properties. 
 
The primary drawback of the biomineralization approach is the 
relatively low photoluminescence intensity displayed by our 
nanocrystals even after ZnS capping, when compared to those 
fabricated at high temperature in the organic phase via traditional 
chemical routes.13,61 This is most likely due to the combination of 
the aqueous solvent and low temperature syn-thesis conditions 
employed. As noted, the quantum yield of 
 
chemically synthesized materials is reduced significantly upon phase 
transfer to the aqueous phase due to relatively poor capping by the 
aqueous stabilizing ligands.12,13 While some groups have reported 
quantum yields of up to 38% for aqueous synthesized CuInS2/ZnS 
core/shell nanocrystals, these alternative chemical synthesis routes 
utilize elevated tempera-tures and/or pressure.22 Growth at lower 
temperatures likely leads to a greater intrinsic defect population in 
the particles. However, this must be placed in context with the 
relative infancy of this enzymatic biomineralization approach to 
func-tional nanomaterial synthesis when compared to the more tra-
ditional routes. We anticipate that further developments of these 
embryonic biomineralized synthesis protocols will occur over time 
and lead to higher quality materials, just as they have over the past 
two decades for the chemical synthesis protocols. 
 
 
 
 
Conclusions 
 
This work has unambiguously demonstrated the direct bio-
mineralization of CuInS2, (CuInZn)S2, and CuInS2/ZnS core/shell 
quantum dots in the aqueous phase using a single enzyme, namely 
CSE. The CuInS2 and (CuInZn)S2 alloy nanocrystals are formed 
using a two-step nucleation process; the first step creates soluble In-
S complexes stabilized by L-cysteine, while the second step 
immediately forms CuInS2 or (CuInZn)S2 nanoparticles following 
the addition of the corresponding non-indium precursor(s). The CSE 
can also be utilized for sub-sequent ZnS shell growth on CuInS2, and 
is achieved by adding zinc acetate to the preformed CuInS2 quantum 
dots, resulting in a dramatic improvement in their photo-
luminescence performance. The resultant CuInS2/ZnS particles can 
be successfully conjugated to an IgG antibody using EDC/ NHS 
cross-linkers and then utilized for the specific tagging of EGFR 
receptors on THP-1 leukemia cells and used for their subsequent 
visualization in confocal fluorescence optical microscopy 
experiments. 
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